Curriculum Vitae

Nadja Windisch

Personal

Name:                      Nadja Windisch-Perci

Born:                        21.09.1979/Graz

Marital Status:          married

E-Mail:                     This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone Number.:        0699/10 49 79 96

 

Education and Work Experience

Since 08/2010           Clinical and Health Psychologist at Wendepunkt Graz

                                  Bauernhuber & Windisch GesbR

Since 01/2008           Clinical and Health Psychologist at Gesundheitseinrichtung Josefhof

03/2007 – 04/2008   Psychologist at Sonderkrankenanstalt-(Rehabilitationszentrum) St. Radegund

04/2002 – 02/2004   Tutor and social care for children at “Pflegeelternverein”, Graz, Austria

09/2003 – 04/2011   Clinical Research Associate at JSW-Research GmbH, Graz, Austria       

SS 2003                     Foreign country semester at University Autonoma de Barcelona, Barcelona, Spain

1998 – 2005              Psychology study at the at the Karl – Franzens University of Graz, Austria

06/1998                     A-Levels

1996                          Foreign country semester at Agoura High School, California, USA

1990 – 1998              “Bundesrealgymnasium” Lichtenfels, Austria

1986 – 1990              Elementary school St. Radegund, Austria

Experience in clinical trials

2009 – 2010:

Phase II, double blind, Venous Thromboembolism   Monitoring 1 site, Austria

 

2008 – 2011:

Phase III, secondary prevention of   venous Thromboembolism

Monitoring, 2 sites, Austria

Submissions to EC and CA

 

2007 – 2008:
  Phase III, secondary prevention of venous Thromboembolism
  Study Management, Monitoring 3 sites, Submissions to EC and CA

 

2007 – 2009:
  Phase III, acute symptomatic venous Thromboembolism
  Study Management, Monitoring 3 sites, Submissions to EC and CA

 

2007:
  Phase II, double-blind, Obesity
  Co-Monitoring 1 international site (Switzerland)

 

2007:
  Phase I, (COPD)
  Co-Monitoring 1 international site (Switzerland)

 

2006:
  Phase I, Alzheimer Studies (Single Dosing, Multiple Dosing, Alcohol   Interaction)
  Audit (Spain)

 

2005 – 2008:
  Phase III, double-blind, Atherosclerosis and Diabetes
  Study Management, Monitoring 1 international site (Spain), Co-Monitoring 1   international site (Spain), Preparation of Submission to EC and CA

 

2004 – 2008:
  Phase IIb, double blind, Alzheimer's Disease

Trainer at   Investigator's Meeting, Monitoring 1 international site (Spain), Co-Monitoring 2 international sites (Spain)

 

2004 – 2006:
  Phase IIb, open label, Alzheimer's Disease
  Monitoring 3 national sites (Austria), Co-monitoring  international sites (Croatia, Spain)

 

2004 – 2006:
  Phase IIb (CSF!), double blind, Alzheimer's Disease
  Monitoring 1 international site (Spain), Co-monitoring international sites   (Serbia, Croatia, Spain)

 

                                       
   

11/2010

   

Investigator´s Meeting on Alzheimer´s Disease, Loipersdorf, Austria

   

Trainer at Investigators´s Meeting – Psychological Ratings

   

 

   
   

06/2010

   

Investigator´s Meeting on Alzheimer´s Disease, Loipersdorf, Austria

   

Trainer at Investigators´s Meeting – CRA Training

   

 

   

10/2008:

   

Investigator´s Meeting on Alzheimer´s Disease, Vienna , Austria

   

Trainer at Investigators´s Meeting

   

 

   
   

2006:
    3rd International Congress on interdisciplinary gerontology incl.     Alzheimer’s Disease Academy, Bad Ischl,      Austria

   

 

   
   

04/2005:
    Investigator’s Meeting on Atherosclerosis and Diabetes, Québec,      Canada

   

 

   

 
                                                 
   

07/2004:
    Investigator’s Meeting on Alzheimer’s Disease, Vienna, Austria
      

05/2004:
    Investigator’s Meeting on Alzheimer’s Disease, Malaga, Spain   

   

12/2003:
   1st International Winter-Symposium on Alzheimer’s Disease, Zürs, Austria   

 

04/2004

Advanced Good Clinical Practice (GCP) Compliance: Turning Theory into Practice (Training with Danielle Jacobs)

 

03/2004 - 05/2004       

Certificate CRA Basis - HealthCareConsulting, Vienna, AUSTRIA

Module 1: Legal Foundations for Clinical Trials using an IMP

Module 2: Duties and Responsibilities of the Clinical Monitor

Module 3: Management and Organization of Clinical Trials

Module 4: Clinical Trials and Regulatory Authority Purposes

 

Oct. 2003   

The legal foundations for clinical trials

Oct. 2003   

Clinical trials from the vision of a public authority 

April 2004  

Advanced Good Clinical Practice (GCP) Compliance: Turning Theory into Practice

 

 

Languages

 

German, English, Spanish

 

 

                                                                       Graz, 25.11.2013